Search Results 111-120 of 16361 for Ureaplasma urealyticum

  1. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    This study will evaluate efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI). Enrolled ...

  2. A Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection - Mayo Clinic

    difficile infection (pCDI) at high risk for recurrence or subjects with recurrent C. difficile infections (rCDI). Participation eligibility. Participant ...

  3. Mucosal and Microbiota Changes During Acute Campylobacteriosis - Mayo Clinic

    About this study. Gastrointestinal (GI) infection with Campylobacter causes inflammation in the bowel and can change bacteria in the gut.

  4. Genetic Expression in Osteolysis, Infection, Arthrofibrosis & Metal Reactions in THA & TKA: A Microarray Analysis to Characterize Individual Host Response to the Molecular Mechanisms of Loosening and Arthrofibrosis - Mayo Clinic

    Genetic Expression in Osteolysis, Infection, Arthrofibrosis & Metal Reactions in THA & TKA: A Microarray Analysis to Characterize Individual Host Response to ...

  5. Diarrhea Causes - Mayo Clinic

    Salmonella infection or other infections that may be caused by bacteria. Shigella infection; Stomach surgery; Traveler's diarrhea. Chronic diarrhea causes may ...

  6. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    Understanding of how best to treat inflammatory bowel disease (IBD) has evolved over the last ten years. Evidence now suggests that the most effective ...

  7. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    Clostridium difficile infection (CDI) continues to be a frequent and potentially severe infection. There is currently no validated clinical tool for use at ...

  8. Treatment of Recurrent Clostridium Difficile Infection with RBX7455 - Mayo Clinic

    ... infection (CDI) in subjects who have had at least one recurrence after a primary episode (i.e., at least two episodes) and have completed at least two ...

  9. Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients - Mayo Clinic

    diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial. Participation eligibility. Participant eligibility ...

  10. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    Understanding of how best to treat inflammatory bowel disease (IBD) has evolved over the last ten years. Evidence now suggests that the most effective ...